logo
Select company
Select metric
Ticker Information

Ticker

SGMO

Company Name

SANGAMO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SANGAMO THERAPEUTICS INC - Capital Expenditures Coverage Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SGMO - CapEx Coverage Historical data
DateCapital ExpenditureCapital Expenditures CoverageNet Cash Flow - Operations
6/30/2025$ 291K0$ -35.9M
3/31/2025$ 267K0$ -44.63M
12/31/2024$ 267K0$ -67.14M
9/30/2024$ 2.79M0$ -114.33M
6/30/2024$ 5.42M0$ -173.38M
3/31/2024$ 10.96M0$ -207.21M
12/31/2023$ 21.16M0$ -224.84M
9/30/2023$ 25.96M0$ -231.35M
6/30/2023$ 27.63M0$ -237.68M
3/31/2023$ 27.53M0$ -230.95M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SANGAMO THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx Coverage stands at 8.77.
  • Over the past 5 years, SANGAMO THERAPEUTICS INC's average CapEx Coverage has been 8.89.
  • The median CapEx Coverage for SANGAMO THERAPEUTICS INC during this period was 8.77
  • SANGAMO THERAPEUTICS INC reached its highest CapEx Coverage over the past 5 years at 11.55.
  • The lowest CapEx Coverage recorded by SANGAMO THERAPEUTICS INC in the same timeframe 6.36

SANGAMO THERAPEUTICS INC's CapEx Coverage vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx Coverage Benchmarks
CompanyCapEx Coverage
ALEC : ALECTOR INC -BDTX : BLACK DIAMOND THERAPEUTICS INC -THTX : THERATECHNOLOGIES INC 639.64AGEN : AGENUS INC -ENTA : ENANTA PHARMACEUTICALS INC -PLX : PROTALIX BIOTHERAPEUTICS INC -SPRO : SPERO THERAPEUTICS INC -CSBR : CHAMPIONS ONCOLOGY INC 17.64TRDA : ENTRADA THERAPEUTICS INC -CELU : CELULARITY INC -

Definition of Capital Expenditures Coverage

[Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
CF - Operations / CapEx
(=) CapEx Coverage
CapEx Coverage for SANGAMO THERAPEUTICS INC is calculated as follows: CF - Operations [ $ 153.35M ] / CapEx [ $ 17.48M ]
(=) CapEx Coverage [ 8.77 ]

SGMO - Capital Expenditures Coverage, Last 5 years

6.36

Minimum

Mar 31, 2021

11.55

Maximum

Dec 31, 2020

8.89

Average

8.77

Median

CapEx Coverage Benchmark Analysis

The chart above depicts the distribution of CapEx Coverage for companies in the Total Stock Market. The average CapEx Coverage of the companies is 4.41 with a standard deviation of 4.02.
The following table provides additional summary stats:
CapEx Coverage in the Market:
filtered constituents2.21K
min0.01
max17.91
average4.41
median3.01
std4.02